News
Moderna had already started a Phase 1/2 trial of its bird flu (H5N1) vaccine and reported strong early results.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback